* USANA Health Sciences Inc USNA.N reported quarterly
adjusted
earnings of 78 cents per share for the quarter ended in
September. The lone analyst forecast for the quarter was
for earnings of 89 cents per share.
* Revenue fell 15% to $233.30 million from a year ago;
analysts
expected $244.20 million.
* USANA Health Sciences Inc's reported EPS for the quarter
was 78
cents.
* The mean earnings estimate of analysts had fallen by
about 5.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* USANA Health Sciences Inc shares had risen by 1.6% this
quarter and lost 43.7% so far this year.
* The company reported quarterly net income of $14.93
million.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $57.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data October
25 at 10:03 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.89 0.78 Missed
Jun. 30 2022 1.14 1.00 Missed
Mar. 31 2022 1.14 1.15 Beat
Dec. 31 2021 1.28 1.03 Missed